Antithrombotic therapy in atrial fibrillation.

نویسندگان

  • W J Manning
  • D I Silverman
چکیده

Abbreviations: ACUTE 5 Assessment of Cardioversion Using Transesophageal Echocardiography; AF 5 atrial fibrillation; AFASAK 5 Atrial Fibrillation Aspirin and Anticoagulation; AFI 5 Atrial Fibrillation Investigators; BAATAF 5 Boston Area Anticoagulation Trial for Atrial Fibrillation; CAFA 5 Canadian Atrial Fibrillation Anticoagulation; CI 5 confidence interval; DC 5 direct current; EAFT 5 European Atrial Fibrillation Trial; ESPS 5 European Stroke Prevention Study; INR 5 international normalized ratio; LV 5 left ventricular; MI 5 myocardial infarction; NNT 5 number needed to treat for 1 year; OAC 5 oral anticoagulation; PAF 5 paroxysmal atrial fibrillation; RR 5 risk reduction; RRR 5 relative risk reduction; SIFA 5 Studio Italiano Fibrillazione Atriale; SPAF 5 Stroke Prevention in Atrial Fibrillation; SPINAF 5 Stroke Prevention in Nonrheumatic Atrial Fibrillation; TEE 5 transesophageal echocardiography; TIA 5 transient ischemic attack (CHEST 2001; 119:194S–206S)

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls.

OBJECTIVE To determine whether the risk of falling (with a possible increased chance of subdural hematoma) should influence the choice of antithrombotic therapy in elderly patients with atrial fibrillation. DESIGN A Markov decision analytic model was used to determine the preferred treatment strategy (no antithrombotic therapy, long-term aspirin use, or long-term warfarin use) for patients wi...

متن کامل

Improving outpatient warfarin use for hospitalized patients with atrial fibrillation

UNLABELLED Atrial fibrillation affects an estimated 5 million Americans and accounts for approximately 15% of all strokes. Few studies have successfully addressed patient screening, assessment, and introduction of appropriate antithrombotic therapy in patients with atrial fibrillation. OBJECTIVE To assess whether an intervention improved planned antithrombotic prescribing at the time of disch...

متن کامل

Cost-effectiveness of preference-based antithrombotic therapy for patients with nonvalvular atrial fibrillation.

BACKGROUND AND PURPOSE Recent atrial fibrillation guidelines recommend the incorporation of patient preferences into the selection of antithrombotic therapy. However, no trial has examined how incorporating such preferences would affect quality-adjusted survival or medical expenditure. We compared 10-year projections of quality-adjusted survival and medical expenditure associated with two atria...

متن کامل

Nonrheumatic atrial fibrillation. Risk of stroke and role of antithrombotic therapy.

T here has been a long-standing consensus1 that the risk of embolization in patients with atrial fibrillation and rheumatic heart disease, in particular, mitral stenosis, is sufficiently high to justify anticoagulant prophylaxis. However, there has been no consensus in regard to nonrheumatic atrial fibrillation. The recognition that nonrheumatic atrial fibrillation is common and associated with...

متن کامل

Antithrombotic treatment of atrial fibrillation in a regional hospital in Hong Kong.

OBJECTIVE To measure the use, appropriateness, and safety of antithrombotic therapy in Hong Kong Chinese patients with atrial fibrillation. DESIGN Retrospective review. SETTING Regional hospital, Hong Kong. SUBJECTS AND METHODS Medical records of all patients with atrial fibrillation admitted to acute internal medicine wards in April 2000 and between July and October 2001 were reviewed fo...

متن کامل

Analysis of antithrombotic therapy in elderly patients with atrial fibrillation.

This study aimed to analyze the impact factors and outcome of antithrombotic therapy in elderly patients over 65 years old that suffered from atrial fibrillation (AF). A total of 256 elderly patients with AF over 65 years old were divided into 3 groups: 65-74 years old (N = 86), 75-84 years old (N = 122), and over 85 years old (N = 48). The clinical characteristics, antithrombotic therapy, and ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Chest

دوره 102 4 Suppl  شماره 

صفحات  -

تاریخ انتشار 1992